Publications

• Identifying Younger Postmenopausal Women With Osteoporosis Using USPSTF-Recommended Osteoporosis Risk Assessment Tools.
  JAMA Netw Open Volume: 8 Page(s): e250626
  03/03/2025 Authors: Zheng HW; Bui AAT; Ensrud KE; Wright NC; Manson JE; Watts NB; Johnson KC; Shadyab AH; Crandall CJ
• New Challenges: Use and Interpretation of Radius Bone Mineral Density.
  J Clin Endocrinol Metab Volume: 110 Page(s): e1 - e7
  12/18/2024 Authors: Cauley JA; Lui L-Y; LeBoff MS; Watts NB
• What to Do When Denosumab Is Stopped?
  JAMA Netw Open Volume: 7 Page(s): e2443879
  11/04/2024 Authors: Watts NB
• Update on Atypical Femoral Fractures.
  J Bone Joint Surg Am Volume: 106 Page(s): 1819 - 1828
  10/02/2024 Authors: Anderson PA; Kates SL; Watts NB
• The use of denosumab in osteoporosis - an update on efficacy and drug safety.
  Expert Opin Drug Saf Volume: 23 Page(s): 1069 - 1077
  09/01/2024 Authors: Diab DL; Watts NB
• Long-Term Effect of Randomization to Calcium and Vitamin D Supplementation on Health in Older Women : Postintervention Follow-up of a Randomized Clinical Trial.
  Ann Intern Med Volume: 177 Page(s): 428 - 438
  04/01/2024 Authors: Thomson CA; Aragaki AK; Prentice RL; Stefanick ML; Manson JE; Wactawski-Wende J; Watts NB; Van Horn L; Shikany JM; Rohan TE
• Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1.
  Clin Trials Volume: 21 Page(s): 29 - 39
  02/01/2024 Authors: Gross AM; Plotkin SR; Watts NB; Fisher MJ; Klesse LJ; Lessing AJ; McManus ML; Larson AN; Oberlander B; Rios JJ
• Letter to the Editor From Watts and Leslie: Comparisons Between Different Antiosteoporosis Medications on Postfracture Mortality: A Population-based Study.
  J Clin Endocrinol Metab Volume: 108 Page(s): e1759
  11/17/2023 Authors: Watts NB; Leslie WD
• Race and Ethnicity and Fracture Prediction Among Younger Postmenopausal Women in the Women's Health Initiative Study.
  JAMA Intern Med Volume: 183 Page(s): 696 - 704
  07/01/2023 Authors: Crandall CJ; Larson JC; Schousboe JT; Manson JE; Watts NB; Robbins JA; Schnatz P; Nassir R; Shadyab AH; Johnson KC
• Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism.
  J Endocr Soc Volume: 7 Page(s): bvad043
  03/06/2023 Authors: Watts NB; Bilezikian JP; Bone HG; Clarke BL; Denham D; Levine MA; Mannstadt M; Peacock M; Rothman JG; Vokes TJ
• Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials.
  Lancet Volume: 400 Page(s): 896 - 907
  09/17/2022 Authors: Donnez J; Taylor HS; Stewart EA; Bradley L; Marsh E; Archer D; Al-Hendy A; Petraglia F; Watts N; Gotteland J-P
• Romosozumab and Renal Function.
  J Bone Miner Res Volume: 37 Page(s): 1435 - 1436
  08/01/2022 Authors: Watts NB
• Bone Mineral Density Changes Associated With Pregnancy, Lactation, and Medical Treatments in Premenopausal Women and Effects Later in Life.
  J Womens Health (Larchmt) Volume: 30 Page(s): 1416 - 1430
  10/01/2021 Authors: Watts NB; Binkley N; Owens CD; Al-Hendy A; Puscheck EE; Shebley M; Schlaff WD; Simon JA
• Updates on Osteoporosis in Men.
  Endocrinol Metab Clin North Am Volume: 50 Page(s): 239 - 249
  06/01/2021 Authors: Diab DL; Watts NB
• American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 Update.
  Endocr Pract Volume: 27 Page(s): 379 - 380
  04/01/2021 Authors: Watts NB; Camacho PM; Lewiecki EM; Petak SM; AACE/ACE Postmenopausal Osteoporosis Guidelines Task Force
• Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial.
  Osteoporos Int Volume: 32 Page(s): 55 - 61
  01/01/2021 Authors: Watts NB; Dore RK; Baim S; Mitlak B; Hattersley G; Wang Y; Rozental TD; LeBoff MS
• Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women.
  JAMA Intern Med Volume: 180 Page(s): 1232 - 1240
  09/01/2020 Authors: Crandall CJ; Larson J; Wright NC; Laddu D; Stefanick ML; Kaunitz AM; Watts NB; Wactawski-Wende J; Womack CR; Johnson KC
• Correction to: Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis.
  Osteoporos Int Volume: 31 Page(s): 1603 - 1605
  08/01/2020 Authors: Watts NB; Hattersley G; Fitzpatrick LA; Wang Y; Williams GC; Miller PD; Cosman F
• Response to Letter to the Editor: "Risk for Infections During Treatment with Denosumab for Osteoporosis: a Systematic Review and Meta-analysis".
  J Clin Endocrinol Metab Volume: 105
  08/01/2020 Authors: Diker-Cohen T; Rosenberg D; Avni T; Shepshelovich D; Tsvetov G; Gafter-Gvili A
• Factors associated with the contemplative stage of readiness to initiate osteoporosis treatment.
  Osteoporos Int Volume: 31 Page(s): 1283 - 1290
  07/01/2020 Authors: Adami G; Saag KG; Mudano AS; Rahn EJ; Wright NC; Outman RC; Greenspan SL; LaCroix AZ; Nieves JW; Silverman SL
• Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.
  Obstet Gynecol Volume: 135 Page(s): 1313 - 1326
  06/01/2020 Authors: Simon JA; Al-Hendy A; Archer DF; Barnhart KT; Bradley LD; Carr BR; Dayspring T; Feinberg EC; Gillispie V; Hurtado S
• Correction to: Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis.
  Osteoporos Int Volume: 31 Page(s): 1017 - 1018
  05/01/2020 Authors: Watts NB; Hattersley G; Fitzpatrick LA; Wang Y; Williams GC; Miller PD; Cosman F
• AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS- 2020 UPDATE EXECUTIVE SUMMARY.
  Endocr Pract Volume: 26 Page(s): 564 - 570
  05/01/2020 Authors: Camacho PM; Petak SM; Binkley N; Diab DL; Eldeiry LS; Farooki A; Harris ST; Hurley DL; Kelly J; Lewiecki EM
• History of etidronate.
  Bone Volume: 134 Page(s): 115222
  05/01/2020 Authors: Watts NB; Chesnut CH; Genant HK; Harris ST; Jackson RD; Licata AA; Miller PD; Mysiw WJ; Richmond B; Valent D
• Osteoporosis-related Vertebral Fragility Fractures: A Review and Analysis of the American Orthopaedic Association's Own the Bone Database.
  Spine (Phila Pa 1976) Volume: 45 Page(s): E430 - E438
  04/15/2020 Authors: Robinson WA; Carlson BC; Poppendeck H; Wanderman NR; Bunta AD; Murphy S; Sietsema DL; Daffner SD; Edwards BJ; Watts NB
• Short Sleep Is Associated With Low Bone Mineral Density and Osteoporosis in the Women's Health Initiative.
  J Bone Miner Res Volume: 35 Page(s): 261 - 268
  02/01/2020 Authors: Ochs-Balcom HM; Hovey KM; Andrews C; Cauley JA; Hale L; Li W; Bea JW; Sarto GE; Stefanick ML; Stone KL
• Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids.
  N Engl J Med Volume: 382 Page(s): 328 - 340
  01/23/2020 Authors: Schlaff WD; Ackerman RT; Al-Hendy A; Archer DF; Barnhart KT; Bradley LD; Carr BR; Feinberg EC; Hurtado SM; Kim J
• Proceedings of the 2019 Santa Fe Bone Symposium: New Concepts in the Care of Osteoporosis and Rare Bone Diseases.
  J Clin Densitom Volume: 23 Page(s): 1 - 20
  01/01/2020 Authors: Lewiecki EM; Bilezikian JP; Kagan R; Krakow D; McClung MR; Miller PD; Rush ET; Shuhart CR; Watts NB; Yu EW
• Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
  Lancet Diabetes Endocrinol Volume: 7 Page(s): 899 - 911
  12/01/2019 Authors: McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP
• Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism.
  J Clin Endocrinol Metab Volume: 104 Page(s): 5136 - 5147
  11/01/2019 Authors: Mannstadt M; Clarke BL; Bilezikian JP; Bone H; Denham D; Levine MA; Peacock M; Rothman J; Shoback DM; Warren ML
• Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program.
  Diabetologia Volume: 62 Page(s): 1854 - 1867
  10/01/2019 Authors: Zhou Z; Jardine M; Perkovic V; Matthews DR; Mahaffey KW; de Zeeuw D; Fulcher G; Desai M; Oh R; Simpson R
• Invasive Oral Procedures and Events in Postmenopausal Women With Osteoporosis Treated With Denosumab for Up to 10 Years.
  J Clin Endocrinol Metab Volume: 104 Page(s): 2443 - 2452
  06/01/2019 Authors: Watts NB; Grbic JT; Binkley N; Papapoulos S; Butler PW; Yin X; Tierney A; Wagman RB; McClung M
• Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis.
  Osteoporos Int Volume: 30 Page(s): 1187 - 1194
  06/01/2019 Authors: Watts NB; Hattersley G; Fitzpatrick LA; Wang Y; Williams GC; Miller PD; Cosman F
• Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.
  Volume: 132 Page(s): 1252 - 1264
  11/01/2018 Authors: Carr BR; Stewart EA; Archer DF; Al-Hendy A; Bradley L; Watts NB; Diamond MP; Gao J; Owens CD; Chwalisz K
• Re: A History of Pivotal Advances in Clinical Research Into Bone and Mineral Diseases.
  J Bone Miner Res Volume: 33 Page(s): 1900 - 1901
  10/01/2018 Authors: Miller PD; Bilezikian JP; Lewiecki EM; Watts NB; Carey JJ
• Postmenopausal Osteoporosis: A Clinical Review.
  J Womens Health (Larchmt) Volume: 27 Page(s): 1093 - 1096
  09/01/2018 Authors: Watts NB
• Long-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension Studies.
  Obstet Gynecol Volume: 132 Page(s): 147 - 160
  07/01/2018 Authors: Surrey E; Taylor HS; Giudice L; Lessey BA; Abrao MS; Archer DF; Diamond MP; Johnson NP; Watts NB; Gallagher JC
• ACUTE PHASE REACTIONS AFTER ZOLEDRONIC ACID INFUSION: PROTECTIVE ROLE OF 25-HYDROXYVITAMIN D AND PREVIOUS ORAL BISPHOSPHONATE THERAPY.
  Endocr Pract Volume: 24 Page(s): 405 - 410
  05/01/2018 Authors: Crotti C; Watts NB; De Santis M; Ceribelli A; Fabbriciani G; Cavaciocchi F; Marasini B; Selmi C; Massarotti M
• Evaluation of a Multimodal, Direct-to-Patient Educational Intervention Targeting Barriers to Osteoporosis Care: A Randomized Clinical Trial.
  J Bone Miner Res Volume: 33 Page(s): 763 - 772
  05/01/2018 Authors: Danila MI; Outman RC; Rahn EJ; Mudano AS; Redden DT; Li P; Allison JJ; Anderson FA; Wyman A; Greenspan SL
• Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women.
  Arch Osteoporos Volume: 13 Page(s): 33
  03/21/2018 Authors: Yusuf AA; Cummings SR; Watts NB; Feudjo MT; Sprafka JM; Zhou J; Guo H; Balasubramanian A; Cooper C
• Self-perception of fracture risk: what can it tell us?
  Osteoporos Int Volume: 28 Page(s): 3495 - 3500
  12/01/2017 Authors: Litwic AE; Compston JE; Wyman A; Siris ES; Gehlbach SH; Adachi JD; Chapurlat R; Dez-Prez A; LaCroix AZ; Nieves JW
• Adverse bone effects of medications used to treat non-skeletal disorders.
  Osteoporos Int Volume: 28 Page(s): 2741 - 2746
  10/01/2017 Authors: Watts NB
• Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist.
  N Engl J Med Volume: 377 Page(s): 28 - 40
  07/06/2017 Authors: Taylor HS; Giudice LC; Lessey BA; Abrao MS; Kotarski J; Archer DF; Diamond MP; Surrey E; Johnson NP; Watts NB
• Safety Observations With 3 Years of Denosumab Exposure: Comparison Between Subjects Who Received Denosumab During the Randomized FREEDOM Trial and Subjects Who Crossed Over to Denosumab During the FREEDOM Extension.
  J Bone Miner Res Volume: 32 Page(s): 1481 - 1485
  07/01/2017 Authors: Watts NB; Brown JP; Papapoulos S; Lewiecki EM; Kendler DL; Dakin P; Wagman RB; Wang A; Daizadeh NS; Smith S
• Responses to Treatment With Teriparatide in Patients With Atypical Femur Fractures Previously Treated With Bisphosphonates.
  J Bone Miner Res Volume: 32 Page(s): 1027 - 1033
  05/01/2017 Authors: Watts NB; Aggers D; McCarthy EF; Savage T; Martinez S; Patterson R; Carrithers E; Miller PD
• Osteoporosis and Fracture Risk Evaluation and Management: Shared Decision Making in Clinical Practice.
  JAMA Volume: 317 Page(s): 253 - 254
  01/17/2017 Authors: Watts NB; Manson JE
• Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ.
  J Clin Densitom Volume: 20 Page(s): 8 - 24
  01/01/2017 Authors: Khan AA; Morrison A; Kendler DL; Rizzoli R; Hanley DA; Felsenberg D; McCauley LK; O'Ryan F; Reid IR; Ruggiero SL
• No Increase in Fractures After Stopping Hormone Therapy: Results From the Women's Health Initiative.
  J Clin Endocrinol Metab Volume: 102 Page(s): 302 - 308
  01/01/2017 Authors: Watts NB; Cauley JA; Jackson RD; LaCroix AZ; Lewis CE; Manson JE; Neuner JM; Phillips LS; Stefanick ML; Wactawski-Wende J
• AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - 2016.
  Endocr Pract Volume: 22 Page(s): 1 - 42
  09/02/2016 Authors: Camacho PM; Petak SM; Binkley N; Clarke BL; Harris ST; Hurley DL; Kleerekoper M; Lewiecki EM; Miller PD; Narula HS
• AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - 2016--EXECUTIVE SUMMARY.
  Endocr Pract Volume: 22 Page(s): 1111 - 1118
  09/01/2016 Authors: Camacho PM; Petak SM; Binkley N; Clarke BL; Harris ST; Hurley DL; Kleerekoper M; Lewiecki EM; Miller PD; Narula HS
• Increase in Fracture Risk Following Unintentional Weight Loss in Postmenopausal Women: The Global Longitudinal Study of Osteoporosis in Women.
  J Bone Miner Res Volume: 31 Page(s): 1466 - 1472
  07/01/2016 Authors: Compston JE; Wyman A; FitzGerald G; Adachi JD; Chapurlat RD; Cooper C; Dez-Prez A; Gehlbach SH; Greenspan SL; Hooven FH
• Evaluation of Bone Mineral Density and Bone Biomarkers in Patients With Type 2 Diabetes Treated With Canagliflozin.
  J Clin Endocrinol Metab Volume: 101 Page(s): 44 - 51
  01/01/2016 Authors: Bilezikian JP; Watts NB; Usiskin K; Polidori D; Fung A; Sullivan D; Rosenthal N
• Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus.
  J Clin Endocrinol Metab Volume: 101 Page(s): 157 - 166
  01/01/2016 Authors: Watts NB; Bilezikian JP; Usiskin K; Edwards R; Desai M; Law G; Meininger G
• Combined Measures of Dynamic Bone Quality and Postural Balance--A Fracture Risk Assessment Approach in Osteoporosis.
  J Clin Densitom Volume: 19 Page(s): 154 - 164
  01/01/2016 Authors: Bhattacharya A; Watts NB; Dwivedi A; Shukla R; Mani A; Diab D
• Urinary Tract Stones and Osteoporosis: Findings From the Women's Health Initiative.
  J Bone Miner Res Volume: 30 Page(s): 2096 - 2102
  11/01/2015 Authors: Carbone LD; Hovey KM; Andrews CA; Thomas F; Sorensen MD; Crandall CJ; Watts NB; Bethel M; Johnson KC
• Taxonomy of rare genetic metabolic bone disorders.
  Osteoporos Int Volume: 26 Page(s): 2529 - 2558
  10/01/2015 Authors: Masi L; Agnusdei D; Bilezikian J; Chappard D; Chapurlat R; Cianferotti L; Devolgelaer J-P; El Maghraoui A; Ferrari S; Javaid MK
• Associations of menopausal vasomotor symptoms with fracture incidence.
  J Clin Endocrinol Metab Volume: 100 Page(s): 524 - 534
  02/01/2015 Authors: Crandall CJ; Aragaki A; Cauley JA; Manson JE; LeBlanc E; Wallace R; Wactawski-Wende J; LaCroix A; O'Sullivan MJ; Vitolins M
• International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study.
  Osteoporos Int Volume: 26 Page(s): 419 - 420
  01/01/2015 Authors: Silverman S; Curtis J; Saag K; Flahive J; Adachi J; Anderson F; Chapurlat R; Cooper C; Diez-Perez A; Greenspan S
• Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus.
  J Bone Miner Res Volume: 30 Page(s): 3 - 23
  01/01/2015 Authors: Khan AA; Morrison A; Hanley DA; Felsenberg D; McCauley LK; O'Ryan F; Reid IR; Ruggiero SL; Taguchi A; Tetradis S
• Comparison of fracture risk prediction by the US Preventive Services Task Force strategy and two alternative strategies in women 50-64 years old in the Women's Health Initiative.
  J Clin Endocrinol Metab Volume: 99 Page(s): 4514 - 4522
  12/01/2014 Authors: Crandall CJ; Larson JC; Watts NB; Gourlay ML; Donaldson MG; LaCroix A; Cauley JA; Wactawski-Wende J; Gass ML; Robbins JA
• The North American Menopause Society recommendations for clinical care of midlife women.
  Menopause Volume: 21 Page(s): 1038 - 1062
  10/01/2014 Authors: Shifren JL; Gass MLS; NAMS Recommendations for Clinical Care of Midlife Women Working Group
• Osteoporosis screening in postmenopausal women 50 to 64 years old: comparison of US Preventive Services Task Force strategy and two traditional strategies in the Women's Health Initiative.
  J Bone Miner Res Volume: 29 Page(s): 1661 - 1666
  07/01/2014 Authors: Crandall CJ; Larson J; Gourlay ML; Donaldson MG; LaCroix A; Cauley JA; Wactawski-Wende J; Gass ML; Robbins JA; Watts NB
• Insights from the Global Longitudinal Study of Osteoporosis in Women (GLOW).
  Nat Rev Endocrinol Volume: 10 Page(s): 412 - 422
  07/01/2014 Authors: Watts NB; GLOW investigators
• Long-term risks of bisphosphonate therapy.
  Arq Bras Endocrinol Metabol Volume: 58 Page(s): 523 - 529
  07/01/2014 Authors: Watts NB
• Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBDs): What the Endocrinologist Needs to Know.
  Endocr Pract Volume: 20 Page(s): 500 - 516
  05/01/2014 Authors: Zangeneh F; Clarke BL; Hurley DL; Watts NB; Miller PD
• The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group.
  Osteoporos Int Volume: 25 Page(s): 1439 - 1443
  05/01/2014 Authors: Siris ES; Adler R; Bilezikian J; Bolognese M; Dawson-Hughes B; Favus MJ; Harris ST; Jan de Beur SM; Khosla S; Lane NE
• Advances in target-specific therapy for osteoporosis.
  J Clin Endocrinol Metab Volume: 99 Page(s): 1149 - 1151
  04/01/2014 Authors: Watts NB; Bilezikian JP
• Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW).
  J Clin Endocrinol Metab Volume: 99 Page(s): 817 - 826
  03/01/2014 Authors: FitzGerald G; Compston JE; Chapurlat RD; Pfeilschifter J; Cooper C; Hosmer DW; Adachi JD; Anderson FA; Dez-Prez A; Greenspan SL
• Use of drug holidays in women taking bisphosphonates.
  Menopause Volume: 21 Page(s): 195 - 197
  02/01/2014 Authors: Diab DL; Watts NB
• Obesity, health-care utilization, and health-related quality of life after fracture in postmenopausal women: Global Longitudinal Study of Osteoporosis in Women (GLOW).
  Calcif Tissue Int Volume: 94 Page(s): 223 - 231
  02/01/2014 Authors: Compston JE; Flahive J; Hooven FH; Anderson FA; Adachi JD; Boonen S; Chapurlat RD; Cooper C; Dez-Perez A; Greenspan SL
• Denosumab in osteoporosis.
  Expert Opin Drug Saf Volume: 13 Page(s): 247 - 253
  02/01/2014 Authors: Diab DL; Watts NB
• Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW).
  J Bone Miner Res Volume: 29 Page(s): 487 - 493
  02/01/2014 Authors: Compston JE; Flahive J; Hosmer DW; Watts NB; Siris ES; Silverman S; Saag KG; Roux C; Rossini M; Pfeilschifter J
• Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW).
  J Bone Miner Res Volume: 29 Page(s): 260 - 267
  01/01/2014 Authors: Dez-Prez A; Adachi JD; Adami S; Anderson FA; Boonen S; Chapurlat R; Compston JE; Cooper C; Gehlbach SH; Greenspan SL
• Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study.
  Osteoporos Int Volume: 25 Page(s): 85 - 95
  01/01/2014 Authors: Gregson CL; Dennison EM; Compston JE; Adami S; Adachi JD; Anderson FA; Boonen S; Chapurlat R; Dez-Prez A; Greenspan SL
• Postmenopausal osteoporosis.
  Curr Opin Endocrinol Diabetes Obes Volume: 20 Page(s): 501 - 509
  12/01/2013 Authors: Diab DL; Watts NB
• Secondary osteoporosis: differential diagnosis and workup.
  Clin Obstet Gynecol Volume: 56 Page(s): 686 - 693
  12/01/2013 Authors: Diab DL; Watts NB
• A clinician performance initiative to improve quality of care for patients with osteoporosis.
  J Womens Health (Larchmt) Volume: 22 Page(s): 853 - 861
  10/01/2013 Authors: Greenspan SL; Bilezikian JP; Watts NB; Berry CA; Mencia WA; Stowell SA; Karcher RB
• Effectiveness of risedronate and alendronate on nonvertebral fractures: an observational study through 2 years of therapy.
  Osteoporos Int Volume: 24 Page(s): 2345 - 2352
  08/01/2013 Authors: Lindsay R; Watts NB; Lange JL; Delmas PD; Silverman SL
• Skeletal health in long-duration astronauts: nature, assessment, and management recommendations from the NASA Bone Summit.
  J Bone Miner Res Volume: 28 Page(s): 1243 - 1255
  06/01/2013 Authors: Orwoll ES; Adler RA; Amin S; Binkley N; Lewiecki EM; Petak SM; Shapses SA; Sinaki M; Watts NB; Sibonga JD
• Diagnosis and treatment of osteoporosis in older adults.
  Endocrinol Metab Clin North Am Volume: 42 Page(s): 305 - 317
  06/01/2013 Authors: Diab DL; Watts NB
• An increased rate of falling leads to a rise in fracture risk in postmenopausal women with self-reported osteoarthritis: a prospective multinational cohort study (GLOW).
  Ann Rheum Dis Volume: 72 Page(s): 911 - 917
  06/01/2013 Authors: Prieto-Alhambra D; Nogues X; Javaid MK; Wyman A; Arden NK; Azagra R; Cooper C; Adachi JD; Boonen S; Chapurlat RD
• When, where and how osteoporosis-associated fractures occur: an analysis from the Global Longitudinal Study of Osteoporosis in Women (GLOW).
  PLoS One Volume: 8 Page(s): e83306
  01/01/2013 Authors: Costa AG; Wyman A; Siris ES; Watts NB; Silverman S; Saag KG; Roux C; Rossini M; Pfeilschifter J; Nieves JW
• 2013 International Society for Clinical Densitometry Position Development Conference: Task Force on Normative Databases.
  J Clin Densitom Volume: 16 Page(s): 472 - 481
  01/01/2013 Authors: Watts NB; Leslie WD; Foldes AJ; Miller PD
• Osteoporosis in men.
  Endocr Pract Volume: 19 Page(s): 834 - 838
  01/01/2013 Authors: Watts NB
• Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW).
  Osteoporos Int Volume: 24 Page(s): 59 - 67
  01/01/2013 Authors: Ioannidis G; Flahive J; Pickard L; Papaioannou A; Chapurlat RD; Saag KG; Silverman S; Anderson FA; Gehlbach SH; Hooven FH
• Characteristics associated with anti-osteoporosis medication use: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort.
  Bone Volume: 51 Page(s): 975 - 980
  12/01/2012 Authors: Guggina P; Flahive J; Hooven FH; Watts NB; Siris ES; Silverman S; Roux C; Pfeilschifter J; Greenspan SL; Dez-Prez A
• Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW).
  Osteoporos Int Volume: 23 Page(s): 2863 - 2871
  12/01/2012 Authors: Roux C; Wyman A; Hooven FH; Gehlbach SH; Adachi JD; Chapurlat RD; Compston JE; Cooper C; Dez-Prez A; Greenspan SL
• Mechanical loading, damping, and load-driven bone formation in mouse tibiae.
  Bone Volume: 51 Page(s): 810 - 818
  10/01/2012 Authors: Dodge T; Wanis M; Ayoub R; Zhao L; Watts NB; Bhattacharya A; Akkus O; Robling A; Yokota H
• Bisphosphonates in the treatment of osteoporosis.
  Endocrinol Metab Clin North Am Volume: 41 Page(s): 487 - 506
  09/01/2012 Authors: Diab DL; Watts NB
• Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women.
  Osteoporos Int Volume: 23 Page(s): 2179 - 2188
  08/01/2012 Authors: Pfeilschifter J; Cooper C; Watts NB; Flahive J; Saag KG; Adachi JD; Boonen S; Chapurlat R; Compston JE; Dez-Prez A
• Osteoporosis in men: an Endocrine Society clinical practice guideline.
  J Clin Endocrinol Metab Volume: 97 Page(s): 1802 - 1822
  06/01/2012 Authors: Watts NB; Adler RA; Bilezikian JP; Drake MT; Eastell R; Orwoll ES; Finkelstein JS; Endocrine Society
• Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW).
  Bone Volume: 50 Page(s): 1288 - 1293
  06/01/2012 Authors: Dennison EM; Compston JE; Flahive J; Siris ES; Gehlbach SH; Adachi JD; Boonen S; Chapurlat R; Dez-Prez A; Anderson FA
• Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women.
  J Am Geriatr Soc Volume: 60 Page(s): 455 - 461
  03/01/2012 Authors: Greenspan SL; Wyman A; Hooven FH; Adami S; Gehlbach S; Anderson FA; Boone S; Lacroix AZ; Lindsay R; Netelenbos JC
• Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women.
  J Bone Miner Res Volume: 27 Page(s): 645 - 653
  03/01/2012 Authors: Gehlbach S; Saag KG; Adachi JD; Hooven FH; Flahive J; Boonen S; Chapurlat RD; Compston JE; Cooper C; Dez-Perez A
• Fracture risk in glucocorticoid-induced osteoporosis: comment on the article by Grossman et al.
  Arthritis Care Res (Hoboken) Volume: 64 Page(s): 157
  01/01/2012 Authors: Watts NB
• Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?
  Osteoporos Int Volume: 23 Page(s): 327 - 337
  01/01/2012 Authors: Watts NB; Roux C; Modlin JF; Brown JP; Daniels A; Jackson S; Smith S; Zack DJ; Zhou L; Grauer A
• Obesity is not protective against fracture in postmenopausal women: GLOW.
  Am J Med Volume: 124 Page(s): 1043 - 1050
  11/01/2011 Authors: Compston JE; Watts NB; Chapurlat R; Cooper C; Boonen S; Greenspan S; Pfeilschifter J; Silverman S; Dez-Prez A; Lindsay R
• Predicting fractures in an international cohort using risk factor algorithms without BMD.
  J Bone Miner Res Volume: 26 Page(s): 2770 - 2777
  11/01/2011 Authors: Sambrook PN; Flahive J; Hooven FH; Boonen S; Chapurlat R; Lindsay R; Nguyen TV; Dez-Perez A; Pfeilschifter J; Greenspan SL
• Longitudinal change in hip fracture incidence after starting risedronate or raloxifene: an observational study.
  J Bone Miner Metab Volume: 29 Page(s): 561 - 570
  09/01/2011 Authors: Ferrari S; Nakamura T; Hagino H; Fujiwara S; Lange JL; Watts NB
• Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW).
  Bone Volume: 49 Page(s): 493 - 498
  09/01/2011 Authors: Dez-Prez A; Hooven FH; Adachi JD; Adami S; Anderson FA; Boonen S; Chapurlat R; Compston JE; Cooper C; Delmas P
• Bone turnover markers and bone mineral density response with risedronate therapy: relationship with fracture risk and patient adherence.
  J Bone Miner Res Volume: 26 Page(s): 1662 - 1669
  07/01/2011 Authors: Eastell R; Vrijens B; Cahall DL; Ringe JD; Garnero P; Watts NB
• Bisphosphonates for postmenopausal osteoporosis.
  Bone Volume: 49 Page(s): 82 - 88
  07/01/2011 Authors: Eastell R; Walsh JS; Watts NB; Siris E
• The Fracture Risk Assessment Tool (FRAX): applications in clinical practice.
  J Womens Health (Larchmt) Volume: 20 Page(s): 525 - 531
  04/01/2011 Authors: Watts NB
• A backbone for FRAX?
  J Bone Miner Res Volume: 26 Page(s): 458 - 459
  03/01/2011 Authors: Watts NB; Diab DL
• Lack of association between 25(OH)D levels and incident type 2 diabetes in older women.
  Diabetes Care Volume: 34 Page(s): 628 - 634
  03/01/2011 Authors: Robinson JG; Manson JE; Larson J; Liu S; Song Y; Howard BV; Phillips L; Shikany JM; Allison M; Curb JD
• Osteoporosis update from the 2010 santa fe bone symposium.
  J Clin Densitom Volume: 14 Page(s): 1 - 21
  01/01/2011 Authors: Lewiecki EM; Bilezikian JP; Khosla S; Marcus R; McClung MR; Miller PD; Watts NB; Maricic M
• Failure to perceive increased risk of fracture in women 55years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW).
  Osteoporos Int Volume: 22 Page(s): 27 - 35
  01/01/2011 Authors: Siris ES; Gehlbach S; Adachi JD; Boonen S; Chapurlat RD; Compston JE; Cooper C; Delmas P; Dez-Prez A; Hooven FH
• Estimating bisphosphonate use and fracture reduction among US women aged 45 years and older, 2001-2008.
  J Bone Miner Res Volume: 26 Page(s): 3 - 11
  01/01/2011 Authors: Siris ES; Pasquale MK; Wang Y; Watts NB
• "Evidence-based" or "logic-based" medicine?
  Osteoporos Int Volume: 21 Page(s): 1681 - 1683
  10/01/2010 Authors: Blank RD; Bilezikian JP; Bonnick SL; Laster AJ; Leib ES; Lewiecki EM; Miller PD; Watts NB; Binkley N
• Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women.
  Mayo Clin Proc Volume: 85 Page(s): 806 - 813
  09/01/2010 Authors: Adachi JD; Adami S; Gehlbach S; Anderson FA; Boonen S; Chapurlat RD; Compston JE; Cooper C; Delmas P; Dez-Prez A
• Long-term use of bisphosphonates in osteoporosis.
  J Clin Endocrinol Metab Volume: 95 Page(s): 1555 - 1565
  04/01/2010 Authors: Watts NB; Diab DL
• Filtering FRAX.
  Osteoporos Int Volume: 21 Page(s): 537 - 541
  04/01/2010 Authors: Watts NB; Siris ES; Cummings SR; Bauer DC
• The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK.
  Osteoporos Int Volume: 21 Page(s): 569 - 577
  04/01/2010 Authors: Cooper C; Steinbuch M; Stevenson R; Miday R; Watts NB
• American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis.
  Endocr Pract Volume: 16 Suppl 3 Page(s): 1 - 37
  01/01/2010 Authors: Watts NB; Bilezikian JP; Camacho PM; Greenspan SL; Harris ST; Hodgson SF; Kleerekoper M; Luckey MM; McClung MR; Pollack RP
• Dynamic bone quality: a noninvasive measure of bone's biomechanical property in osteoporosis.
  J Clin Densitom Volume: 13 Page(s): 228 - 236
  01/01/2010 Authors: Bhattacharya A; Watts NB; Davis K; Kotowski S; Shukla R; Dwivedi AK; Coleman R
• Risedronate on 2 consecutive days a month reduced vertebral fracture risk at 1year compared with historical placebo.
  J Clin Densitom Volume: 13 Page(s): 56 - 62
  01/01/2010 Authors: Watts NB; Brown JP; Cline G
• Bone: bone density screening leads to reduced fracture risk.
  Nat Rev Endocrinol Volume: 6 Page(s): 17 - 18
  01/01/2010 Authors: Watts NB
• Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.
  Gen Dent Volume: 58 Page(s): 484 - 492
  01/01/2010 Authors: Skrepnek GH; Seal B; Tangirala M; Jeffcoat MK; Watts NB; Hay JW
• Clinical value of monitoring BMD in patients treated with bisphosphonates for osteoporosis.
  J Bone Miner Res Volume: 24 Page(s): 1643 - 1646
  10/01/2009 Authors: Watts NB; Lewiecki EM; Bonnick SL; Laster AJ; Binkley N; Blank RD; Geusens PP; Miller PD; Petak SM; Recker RR
• Risk factors for the development of osteoporosis and osteoporotic fractures among older men.
  J Rheumatol Volume: 36 Page(s): 1947 - 1952
  09/01/2009 Authors: Thomas-John M; Codd MB; Manne S; Watts NB; Mongey A-B
• Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis.
  J Bone Miner Res Volume: 24 Page(s): 1544 - 1551
  09/01/2009 Authors: Delmas PD; Munoz F; Black DM; Cosman F; Boonen S; Watts NB; Kendler D; Eriksen EF; Mesenbrink PG; Eastell R
• The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design.
  Osteoporos Int Volume: 20 Page(s): 1107 - 1116
  07/01/2009 Authors: Hooven FH; Adachi JD; Adami S; Boonen S; Compston J; Cooper C; Delmas P; Diez-Perez A; Gehlbach S; Greenspan SL
• FRAX facts.
  J Bone Miner Res Volume: 24 Page(s): 975 - 979
  06/01/2009 Authors: Watts NB; Ettinger B; LeBoff MS
• Vertebral fracture risk is reduced in women who lose femoral neck BMD with teriparatide treatment.
  J Bone Miner Res Volume: 24 Page(s): 1125 - 1131
  06/01/2009 Authors: Watts NB; Miller PD; Kohlmeier LA; Sebba A; Chen P; Wong M; Krohn K
• Low-fat, increased fruit, vegetable, and grain dietary pattern, fractures, and bone mineral density: the Women's Health Initiative Dietary Modification Trial.
  Am J Clin Nutr Volume: 89 Page(s): 1864 - 1876
  06/01/2009 Authors: McTiernan A; Wactawski-Wende J; Wu L; Rodabough RJ; Watts NB; Tylavsky F; Freeman R; Hendrix S; Jackson R; Women's Health Initiative Investigators
• Management of osteoporosis among home health and long-term care patients with a prior fracture.
  South Med J Volume: 102 Page(s): 397 - 404
  04/01/2009 Authors: Warriner AH; Outman RC; Saag KG; Berry SD; Coln-Emeric C; Flood KL; Lyles KW; Tanner SB; Watts NB; Curtis JR
• New guidelines for the prevention and treatment of osteoporosis.
  South Med J Volume: 102 Page(s): 175 - 179
  02/01/2009 Authors: Lewiecki EM; Watts NB
• Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate.
  J Clin Endocrinol Metab Volume: 93 Page(s): 3785 - 3793
  10/01/2008 Authors: Miller PD; Delmas PD; Lindsay R; Watts NB; Luckey M; Adachi J; Saag K; Greenspan SL; Seeman E; Boonen S
• Assessing response to osteoporosis therapy.
  Osteoporos Int Volume: 19 Page(s): 1363 - 1368
  10/01/2008 Authors: Lewiecki EM; Watts NB
• Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.
  Osteoporos Int Volume: 19 Page(s): 733 - 759
  06/01/2008 Authors: Russell RGG; Watts NB; Ebetino FH; Rogers MJ
• Fracture risk remains reduced one year after discontinuation of risedronate.
  Osteoporos Int Volume: 19 Page(s): 365 - 372
  03/01/2008 Authors: Watts NB; Chines A; Olszynski WP; McKeever CD; McClung MR; Zhou X; Grauer A
• Osteonecrosis of the jaw.
  South Med J Volume: 101 Page(s): 160 - 165
  02/01/2008 Authors: Watts NB; Marciani RD
• Osteonecrosis of the jaw: balancing the benefits and risks of oral bisphosphonate treatment for osteoporosis.
  Gen Dent Volume: 56 Page(s): 96 - 102
  01/01/2008 Authors: Jeffcoat M; Watts NB
• Recommendations for the clinical evaluation of agents for treatment of osteoporosis: consensus of an expert panel representing the American Society for Bone and Mineral Research (ASBMR), the International Society for Clinical Densitometry (ISCD), and the National Osteoporosis Foundation (NOF).
  J Bone Miner Res Volume: 23 Page(s): 159 - 165
  01/01/2008 Authors: Silverman SL; Cummings SR; Watts NB; Consensus Panel of the ASBMR, ISCD, and NOF
• National Osteoporosis Foundation 2008 Clinician's Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool (FRAX): what they mean to the bone densitometrist and bone technologist.
  J Clin Densitom Volume: 11 Page(s): 473 - 477
  01/01/2008 Authors: Watts NB; Lewiecki EM; Miller PD; Baim S
• Factors associated with 5-year risk of hip fracture in postmenopausal women.
  JAMA Volume: 298 Page(s): 2389 - 2398
  11/28/2007 Authors: Robbins J; Aragaki AK; Kooperberg C; Watts N; Wactawski-Wende J; Jackson RD; LeBoff MS; Lewis CE; Chen Z; Stefanick ML
• Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
  Volume: 1117 Page(s): 209 - 257
  11/01/2007 Authors: Russell RGG; Xia Z; Dunford JE; Oppermann U; Kwaasi A; Hulley PA; Kavanagh KL; Triffitt JT; Lundy MW; Phipps RJ
• Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research.
  J Bone Miner Res Volume: 22 Page(s): 1479 - 1491
  10/01/2007 Authors: Khosla S; Burr D; Cauley J; Dempster DW; Ebeling PR; Felsenberg D; Gagel RF; Gilsanz V; Guise T; Koka S
• The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.
  Osteoporos Int Volume: 18 Page(s): 1033 - 1046
  08/01/2007 Authors: Kanis JA; Oden A; Johnell O; Johansson H; De Laet C; Brown J; Burckhardt P; Cooper C; Christiansen C; Cummings S
• Assessment of non-vertebral fracture risk in postmenopausal women.
  Ann Rheum Dis Volume: 66 Page(s): 931 - 935
  07/01/2007 Authors: Roux C; Briot K; Horlait S; Varbanov A; Watts NB; Boonen S
• Intraoperative PTH: effect of sample timing and vitamin D status.
  Otolaryngol Head Neck Surg Volume: 136 Page(s): 946 - 951
  06/01/2007 Authors: Statham MM; Watts NB; Steward DL
• Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis.
  J Clin Endocrinol Metab Volume: 92 Page(s): 1296 - 1304
  04/01/2007 Authors: Delmas PD; Vrijens B; Eastell R; Roux C; Pols HAP; Ringe JD; Grauer A; Cahall D; Watts NB; Improving Measurements of Persistence on Actonel Treatment (IMPACT) Investigators
• Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study.
  Osteoporos Int Volume: 18 Page(s): 25 - 34
  01/01/2007 Authors: Silverman SL; Watts NB; Delmas PD; Lange JL; Lindsay R
• Effect of precision error on T-scores and the diagnostic classification of bone status.
  J Clin Densitom Volume: 10 Page(s): 239 - 243
  01/01/2007 Authors: Kiebzak GM; Faulkner KG; Wacker W; Hamdy R; Seier E; Watts NB
• Bone quantity and quality of youths working on a farm-a pilot study.
  J Agromedicine Volume: 12 Page(s): 27 - 38
  01/01/2007 Authors: Bhattacharya A; Watts NB; Gordon J; Shukla R; Waters T; Bartels S; Coleman R
• The prevalence of significant left-right differences in hip bone mineral density.
  Osteoporos Int Volume: 17 Page(s): 1772 - 1780
  12/01/2006 Authors: Hamdy R; Kiebzak GM; Seier E; Watts NB
• Bisphosphonates and osteonecrosis of the jaw.
  Ann Intern Med Volume: 145 Page(s): 791 - 792
  11/21/2006 Authors: Watts NB; Harris ST; McClung MR; Bilezikian JP; Greenspan SL; Luckey MM
• Type 2 diabetes, thiazolidinediones: bad to the bone?
  J Clin Endocrinol Metab Volume: 91 Page(s): 3276 - 3278
  09/01/2006 Authors: Watts NB; D'Alessio DA
• Comparison of serum calcium change following thyroid and nonthyroid neck surgery.
  Otolaryngol Head Neck Surg Volume: 134 Page(s): 901 - 906
  06/01/2006 Authors: Mehta N; Watts NB; Welge JA; Steward D
• Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the women's health initiative randomized trial.
  J Bone Miner Res Volume: 21 Page(s): 817 - 828
  06/01/2006 Authors: Jackson RD; Wactawski-Wende J; LaCroix AZ; Pettinger M; Yood RA; Watts NB; Robbins JA; Lewis CE; Beresford SA; Ko MG
• Hyperbilirubinemia is not a major contributing factor to altered bone mineral density in patients with chronic liver disease.
  J Clin Densitom Volume: 9 Page(s): 105 - 113
  01/01/2006 Authors: Smith DLH; Shire NJ; Watts NB; Schmitter T; Szabo G; Zucker SD
• Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: the 2005 ISCD Official Positions.
  J Clin Densitom Volume: 9 Page(s): 22 - 30
  01/01/2006 Authors: Leslie WD; Adler RA; El-Hajj Fuleihan G; Hodsman AB; Kendler DL; McClung M; Miller PD; Watts NB; International Society for Clinical Densitometry
• What is osteopenia, and what should be done about it?
  Cleve Clin J Med Volume: 73 Page(s): 29 - 32
  01/01/2006 Authors: Watts NB
• Standards for performing DXA in individuals with secondary causes of osteoporosis.
  J Clin Densitom Volume: 9 Page(s): 47 - 57
  01/01/2006 Authors: Khan AA; Hanley DA; Bilezikian JP; Binkley N; Brown JP; Hodsman AB; Josse RG; Kendler DL; Lewiecki EM; Miller PD
• American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause.
  Endocr Pract Volume: 12 Page(s): 315 - 337
  01/01/2006 Authors: Cobin RH; Futterweit W; Ginzburg SB; Goodman NF; Kleerekoper M; Licata AA; Meikle AW; Petak SM; Porte KL; Sellin RV
• Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.
  J Bone Miner Res Volume: 20 Page(s): 2097 - 2104
  12/01/2005 Authors: Watts NB; Geusens P; Barton IP; Felsenberg D
• Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies.
  Osteoporos Int Volume: 16 Page(s): 1291 - 1298
  10/01/2005 Authors: Boonen S; Laan RF; Barton IP; Watts NB
• Review of treatment modalities for postmenopausal osteoporosis.
  South Med J Volume: 98 Page(s): 1000 - 1014
  10/01/2005 Authors: Hamdy RC; Chesnut CH; Gass ML; Holick MF; Leib ES; Lewiecki ME; Maricic M; Watts NB
• Prior oral contraception and postmenopausal fracture: a Women's Health Initiative observational cohort study.
  Fertil Steril Volume: 84 Page(s): 374 - 383
  08/01/2005 Authors: Barad D; Kooperberg C; Wactawski-Wende J; Liu J; Hendrix SL; Watts NB
• Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
  Arch Intern Med Volume: 165 Page(s): 1582 - 1589
  07/25/2005 Authors: Braunstein GD; Sundwall DA; Katz M; Shifren JL; Buster JE; Simon JA; Bachman G; Aguirre OA; Lucas JD; Rodenberg C
• Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT study.
  J Bone Miner Res Volume: 20 Page(s): 557 - 563
  04/01/2005 Authors: Delmas PD; van de Langerijt L; Watts NB; Eastell R; Genant H; Grauer A; Cahall DL; IMPACT Study Group
• Incidence of urinary incontinence in postmenopausal women treated with raloxifene or estrogen.
  Menopause Volume: 12 Page(s): 160 - 164
  03/01/2005 Authors: Goldstein SR; Johnson S; Watts NB; Ciaccia AV; Elmerick D; Muram D
• Guide to bone health and disease in cystic fibrosis.
  Volume: 90 Page(s): 1888 - 1896
  03/01/2005 Authors: Aris RM; Merkel PA; Bachrach LK; Borowitz DS; Boyle MP; Elkin SL; Guise TA; Hardin DS; Haworth CS; Holick MF
• Ibandronate produces significant, similar antifracture efficacy in North American and European women: new clinical findings from BONE.
  Curr Med Res Opin Volume: 21 Page(s): 391 - 401
  03/01/2005 Authors: Chesnut CH; Ettinger MP; Miller PD; Baylink DJ; Emkey R; Harris ST; Wasnich RD; Watts NB; Schimmer RC; Recker RR
• Fundamentals and pitfalls of bone densitometry using dual-energy X-ray absorptiometry (DXA).
  Osteoporos Int Volume: 15 Page(s): 847 - 854
  11/01/2004 Authors: Watts NB
• Official positions of the international society for clinical densitometry.
  J Clin Endocrinol Metab Volume: 89 Page(s): 3651 - 3655
  08/01/2004 Authors: Lewiecki EM; Watts NB; McClung MR; Petak SM; Bachrach LK; Shepherd JA; Downs RW; International Society for Clinical Densitometry
• Diagnosis and evaluation of patients with osteoporosis.
  South Med J Volume: 97 Page(s): 540 - 541
  06/01/2004 Authors: Watts NB
• Two-year efficacy and tolerability of risedronate once a week for the treatment of women with postmenopausal osteoporosis.
  Curr Med Res Opin Volume: 20 Page(s): 757 - 764
  05/01/2004 Authors: Harris ST; Watts NB; Li Z; Chines AA; Hanley DA; Brown JP
• A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.
  Arch Intern Med Volume: 164 Page(s): 871 - 879
  04/26/2004 Authors: Reid IR; Eastell R; Fogelman I; Adachi JD; Rosen A; Netelenbos C; Watts NB; Seeman E; Ciaccia AV; Draper MW
• Efficacy of risedronate on clinical vertebral fractures within six months.
  Curr Med Res Opin Volume: 20 Page(s): 433 - 439
  04/01/2004 Authors: Roux C; Seeman E; Eastell R; Adachi J; Jackson RD; Felsenberg D; Songcharoen S; Rizzoli R; Di Munno O; Horlait S
• Is it ethical to use placebos in osteoporosis clinical trials?
  Curr Osteoporos Rep Volume: 2 Page(s): 31 - 36
  03/01/2004 Authors: Watts NB
• Effects of estrogen plus progestin on health-related quality of life.
  N Engl J Med Volume: 350 Page(s): 622
  02/05/2004 Authors: Watts NB
• Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone.
  J Clin Endocrinol Metab Volume: 89 Page(s): 503 - 510
  02/01/2004 Authors: Amory JK; Watts NB; Easley KA; Sutton PR; Anawalt BD; Matsumoto AM; Bremner WJ; Tenover JL
• Is it ethical to use placebos in osteoporosis clinical trials?
  Curr Rheumatol Rep Volume: 6 Page(s): 79 - 84
  02/01/2004 Authors: Watts NB
• The effect of octreotide on parathyroid carcinoma.
  J Clin Endocrinol Metab Volume: 89 Page(s): 1016
  02/01/2004 Authors: Denney AM; Watts NB
• Standards and guidelines for performing central dual-energy x-ray absorptiometry in premenopausal women, men, and children.
  J Clin Densitom Volume: 7 Page(s): 51 - 64
  01/01/2004 Authors: Khan AA; Bachrach L; Brown JP; Hanley DA; Josse RG; Kendler DL; Leib ES; Lentle BC; Leslie WD; Lewiecki EM
• Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk.
  J Clin Densitom Volume: 7 Page(s): 255 - 261
  01/01/2004 Authors: Watts NB; Cooper C; Lindsay R; Eastell R; Manhart MD; Barton IP; van Staa T-P; Adachi JD
• The American College of Endocrinology and Endocrine University.
  Trans Am Clin Climatol Assoc Volume: 115 Page(s): 333 - 360
  01/01/2004 Authors: Watts NB; Rodbard HW; Hodgson SF; Baskin HJ
• Comparison of risedronate to alendronate and calcitonin for early reduction of nonvertebral fracture risk: results from a managed care administrative claims database.
  J Manag Care Pharm Volume: 10 Page(s): 142 - 151
  01/01/2004 Authors: Watts NB; Worley K; Solis A; Doyle J; Sheer R
• Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
  JAMA Volume: 290 Page(s): 1729 - 1738
  10/01/2003 Authors: Cauley JA; Robbins J; Chen Z; Cummings SR; Jackson RD; LaCroix AZ; LeBoff M; Lewis CE; McGowan J; Neuner J
• Position Development Conference.
  Volume: 96 Page(s): 724 - 725
  07/01/2003 Authors: Lenchik L; Leib ES; Hamdy RC; Binkley NC; Miller PD; Watts NB
• Use of matched historical controls to evaluate the anti-fracture efficacy of once-a-week risedronate.
  Osteoporos Int Volume: 14 Page(s): 437 - 441
  06/01/2003 Authors: Watts NB; Lindsay R; Li Z; Kasibhatla C; Brown J
• Bisphosphonate treatment of osteoporosis.
  Clin Geriatr Med Volume: 19 Page(s): 395 - 414
  05/01/2003 Authors: Watts NB
• Is percutaneous vertebral augmentation (vertebroplasty) effective treatment for painful vertebral fractures?
  Am J Med Volume: 114 Page(s): 326 - 328
  03/01/2003 Authors: Watts NB
• Efficacy of teriparatide and alendronate on nonvertebral fractures.
  J Clin Endocrinol Metab Volume: 88 Page(s): 1402 - 1403
  03/01/2003 Authors: Watts NB
• Risedronate prevents new vertebral fractures in postmenopausal women at high risk.
  J Clin Endocrinol Metab Volume: 88 Page(s): 542 - 549
  02/01/2003 Authors: Watts NB; Josse RG; Hamdy RC; Hughes RA; Manhart MD; Barton I; Calligeros D; Felsenberg D
• American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003.
  Endocr Pract Volume: 9 Page(s): 544 - 564
  01/01/2003 Authors: Hodgson SF; Watts NB; Bilezikian JP; Clarke BL; Gray TK; Harris DW; Johnston CC; Kleerekoper M; Lindsay R; Luckey MM
• The 2002 Canadian bone densitometry recommendations: take-home messages.
  CMAJ Volume: 167 Page(s): 1141 - 1145
  11/12/2002 Authors: Khan AA; Brown JP; Kendler DL; Leslie WD; Lentle BC; Lewiecki EM; Miller PD; Nicholson RL; Olszynski WP; Watts NB
• Lessons learned from the Women's Health Initiative study.
  South Med J Volume: 95 Page(s): 951 - 952
  09/01/2002 Authors: Hamdy RC
• Lessons from the Women's Health Initiative.
  South Med J Volume: 95 Page(s): 952 - 955
  09/01/2002 Authors: Watts NB
• Diagnosis and management of vertebral fractures in elderly adults.
  Am J Med Volume: 113 Page(s): 220 - 228
  08/15/2002 Authors: Papaioannou A; Watts NB; Kendler DL; Yuen CK; Adachi JD; Ferko N
• Bone quality: getting closer to a definition.
  J Bone Miner Res Volume: 17 Page(s): 1148 - 1150
  07/01/2002 Authors: Watts NB
• Osteoporosis 2002: headline news.
  South Med J Volume: 95 Page(s): 570 - 577
  06/01/2002 Authors: Watts N
• Bisphosphonates, statins, osteoporosis, and atherosclerosis.
  South Med J Volume: 95 Page(s): 578 - 582
  06/01/2002 Authors: Watts N
• Combination therapy for postmenopausal osteoporosis.
  Clin Endocrinol (Oxf) Volume: 56 Page(s): 565 - 569
  05/01/2002 Authors: Compston JE; Watts NB
• Localisation of mesenchymal tumours by somatostatin receptor imaging.
  Lancet Volume: 359 Page(s): 761 - 763
  03/02/2002 Authors: Jan de Beur SM; Streeten EA; Civelek AC; McCarthy EF; Uribe L; Marx SJ; Onobrakpeya O; Raisz LG; Watts NB; Sharon M
• Assessment and recommendations on factors contributing to preanalytical variability of urinary pyridinoline and deoxypyridinoline.
  Clin Chem Volume: 48 Page(s): 220 - 235
  02/01/2002 Authors: Vesper HW; Demers LM; Eastell R; Garnero P; Kleerekoper M; Robins SP; Srivastava AK; Warnick GR; Watts NB; Myers GL
• Clinical challenges in osteoporosis. Case 1: screening for osteoporosis in early menopause.
  Semin Arthritis Rheum Volume: 31 Page(s): 284 - 285
  02/01/2002 Authors: Watts NB
• Executive summary International Society for Clinical Densitometry position development conference Denver, Colorado July 20-22, 2001.
  Volume: 5 Suppl Page(s): S1 - S3
  01/01/2002 Authors: Lenchik L; Leib ES; Hamdy RC; Binkley NC; Miller PD; Watts NB; International Society for Clinical Densitometry Position Development Panel and Scientific Advisory Committee
• Standards and guidelines for performing central dual X-ray densitometry from the Canadian Panel of International Society for Clinical Densitometry.
  J Clin Densitom Volume: 5 Page(s): 435 - 445
  01/01/2002 Authors: Khan AA; Brown J; Faulkner K; Kendler D; Lentle B; Leslie W; Miller PD; Nicholson L; Olszynski WP; Watts NB
• Therapies to improve bone mineral density and reduce the risk of fracture: clinical trial results.
  J Reprod Med Volume: 47 Page(s): 82 - 92
  01/01/2002 Authors: Watts NB
• Position statements of the International Society for Clinical Densitometry: methodology.
  Volume: 5 Suppl Page(s): S5 - 10
  01/01/2002 Authors: Leib ES; Lenchik L; Bilezikian JP; Maricic MJ; Watts NB
• Standards and guidelines for performing central dual X-ray densitometry from the Canadian panel of International Society for Clinical Densitometry.
  J Clin Densitom Volume: 5 Page(s): 247 - 257
  01/01/2002 Authors: Khan AA; Brown J; Faulkner K; Kendler D; Lentle B; Leslie W; Miller PD; Nicholson L; Olszynski WP; Watts NB
• Risedronate for the prevention and treatment of postmenopausal osteoporosis: results from recent clinical trials.
  Osteoporos Int Volume: 12 Suppl 3 Page(s): S17 - S22
  12/01/2001 Authors: Watts NB
• Risk factors for kidney stones in older women in the southern United States.
  Am J Med Sci Volume: 322 Page(s): 12 - 18
  07/01/2001 Authors: Hall WD; Pettinger M; Oberman A; Watts NB; Johnson KC; Paskett ED; Limacher MC; Hays J
• Absolute vs. relative numbers in evaluating drug therapy.
  Am Fam Physician Volume: 63 Page(s): 1913 - 1916
  05/15/2001 Authors: McCormack J
• Osteoporotic vertebral fractures.
  Neurosurg Focus Volume: 10 Page(s): E12
  04/15/2001 Authors: Watts NB
• Observational data do not establish cause and effect.
  Arch Intern Med Volume: 161 Page(s): 772
  03/12/2001 Authors: Watts NB
• Treatment of osteoporosis with bisphosphonates.
  Rheum Dis Clin North Am Volume: 27 Page(s): 197 - 214
  02/01/2001 Authors: Watts NB
• Multisite bone ultrasound measurement on North American female reference population.
  J Clin Densitom Volume: 4 Page(s): 239 - 248
  01/01/2001 Authors: Drake WM; McClung M; Njeh CF; Genant HK; Rosen C; Watts N; Kendler DL
• Comparison of bone and total alkaline phosphatase and bone mineral density in postmenopausal osteoporotic women treated with alendronate.
  Osteoporos Int Volume: 12 Page(s): 279 - 288
  01/01/2001 Authors: Watts NB; Jenkins DK; Visor JM; Casal DC; Geusens P
• American Association of Clinical Endocrinologists 2001 Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis.
  Endocr Pract Volume: 7 Page(s): 293 - 312
  01/01/2001 Authors: American Association of Clinical Endocrinologists Osteoporosis Task Force
• Regression to the mean: what does it mean? Using bone density results to monitor treatment of osteoporosis.
  J Clin Densitom Volume: 4 Page(s): 1 - 4
  01/01/2001 Authors: Lenchik L; Watts NB
• Treatment of painful osteoporotic vertebral fractures with percutaneous vertebroplasty or kyphoplasty.
  Osteoporos Int Volume: 12 Page(s): 429 - 437
  01/01/2001 Authors: Watts NB; Harris ST; Genant HK
• Focus on primary care postmenopausal osteoporosis: an update.
  Obstet Gynecol Surv Volume: 55 Page(s): S49 - S55
  12/01/2000 Authors: Watts NB
• A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.
  Am J Med Volume: 109 Page(s): 267 - 276
  09/01/2000 Authors: Chesnut CH; Silverman S; Andriano K; Genant H; Gimona A; Harris S; Kiel D; LeBoff M; Maricic M; Miller P
• Bisphosphonates: safety and efficacy in the treatment and prevention of osteoporosis.
  Am Fam Physician Volume: 61 Page(s): 2731 - 2736
  05/01/2000 Authors: Greenspan SL; Harris ST; Bone H; Miller PD; Orwoll ES; Watts NB; Rosen CJ
• Using bone mineral density T-scores to diagnose postmenopausal osteoporosis.
  Endocr Pract Volume: 6 Page(s): 217 - 218
  01/01/2000 Authors: Watts NB
• Esterified estrogen therapy in postmenopausal women. Relationships of bone marker changes and plasma estradiol to BMD changes: a two-year study.
  Menopause Volume: 7 Page(s): 375 - 382
  01/01/2000 Authors: Watts NB; Nolan JC; Brennan JJ; Yang HM; ESTRATAB/Osteoporosis Study Group
• Clinical use of biochemical markers of bone remodeling: current status and future directions.
  Osteoporos Int Volume: 11 Page(s): 467 - 480
  01/01/2000 Authors: Looker AC; Bauer DC; Chesnut CH; Gundberg CM; Hochberg MC; Klee G; Kleerekoper M; Watts NB; Bell NH
• Changing perceptions in osteoporosis. Markers should be used as adjunct to bone densitometry.
  BMJ Volume: 319 Page(s): 1371 - 1372
  11/20/1999 Authors: Watts NB; Miller PD
• Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.
  JAMA Volume: 282 Page(s): 1344 - 1352
  10/13/1999 Authors: Harris ST; Watts NB; Genant HK; McKeever CD; Hangartner T; Keller M; Chesnut CH; Brown J; Eriksen EF; Hoseyni MS
• Clinical utility of biochemical markers of bone remodeling.
  Clin Chem Volume: 45 Page(s): 1359 - 1368
  08/01/1999 Authors: Watts NB
• Postmenopausal osteoporosis.
  Obstet Gynecol Surv Volume: 54 Page(s): 532 - 538
  08/01/1999 Authors: Watts NB
• The clinical tolerability profile of alendronate.
  Int J Clin Pract Suppl Volume: 101 Page(s): 51 - 61
  04/01/1999 Authors: Watts N; Freedholm D; Daifotis A
• Alendronate increases spine and hip bone mineral density in women with postmenopausal osteoporosis who failed to respond to intermittent cyclical etidronate.
  Bone Volume: 24 Page(s): 65 - 68
  01/01/1999 Authors: Watts NB; Becker P
• Practical clinical application of biochemical markers of bone turnover: Consensus of an expert panel.
  J Clin Densitom Volume: 2 Page(s): 323 - 342
  01/01/1999 Authors: Miller PD; Baran DT; Bilezikian JP; Greenspan SL; Lindsay R; Riggs BL; Watts NB
• Understanding the Bone Mass Measurement Act.
  J Clin Densitom Volume: 2 Page(s): 211 - 217
  01/01/1999 Authors: Watts NB
• How to get the most out of bone densitometry. Results can help assess fracture risk and guide therapy.
  Postgrad Med Volume: 104 Page(s): 77 - 86
  10/01/1998 Authors: Bracker MD; Watts NB
• Treatment of estrogen deficiency symptoms in women surviving breast cancer. The Hormone Foundation, Canadian Breast Cancer Research Initiative, National Cancer Institute of Canada, Endocrine Society, and the University of Virginia Cancer Center and Woman's Place.
  J Clin Endocrinol Metab Volume: 83 Page(s): 1993 - 2000
  06/01/1998
• Treatment of osteoporosis with bisphosphonates.
  Endocrinol Metab Clin North Am Volume: 27 Page(s): 419 - 439
  06/01/1998 Authors: Watts NB
• Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab/Osteoporosis Study Group.
  Arch Intern Med Volume: 157 Page(s): 2609 - 2615
  12/08/1997 Authors: Genant HK; Lucas J; Weiss S; Akin M; Emkey R; McNaney-Flint H; Downs R; Mortola J; Watts N; Yang HM
• Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatment.
  Am J Med Volume: 103 Page(s): 468 - 476
  12/01/1997 Authors: Miller PD; Watts NB; Licata AA; Harris ST; Genant HK; Wasnich RD; Ross PD; Jackson RD; Hoseyni MS; Schoenfeld SL
• Benign symmetric lipomatosis associated with protease inhibitors.
  Lancet Volume: 350 Page(s): 1596
  11/29/1997 Authors: Hengel RL; Watts NB; Lennox JL
• Osteoporosis: prevention, detection and treatment.
  J Med Assoc Ga Volume: 86 Page(s): 224 - 226
  09/01/1997 Authors: Watts NB
• Introduction: management of osteoporosis, 1997.
  Am J Med Sci Volume: 313 Page(s): 1
  01/01/1997 Authors: Watts NB
• Introduction: osteoporosis 1996.
  Am J Med Sci Volume: 312 Page(s): 249 - 250
  12/01/1996 Authors: Watts NB
• Diabetic muscle infarction.
  Am J Med Volume: 101 Page(s): 245 - 250
  09/01/1996 Authors: Umpierrez GE; Stiles RG; Kleinbart J; Krendel DA; Watts NB
• Endocrinology.
  JAMA Volume: 275 Page(s): 1806 - 1807
  06/19/1996 Authors: Watts NB; Blevins LS
• Reproducibility (precision) in alternate site testing. A clinician's perspective.
  Arch Pathol Lab Med Volume: 119 Page(s): 914 - 917
  10/01/1995 Authors: Watts NB
• Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause.
  Obstet Gynecol Volume: 85 Page(s): 529 - 537
  04/01/1995 Authors: Watts NB; Notelovitz M; Timmons MC; Addison WA; Wiita B; Downey LJ
• Disruptive nocturnal behavior in Parkinson's disease and Alzheimer's disease.
  J Geriatr Psychiatry Neurol Volume: 8 Page(s): 107 - 110
  04/01/1995 Authors: Bliwise DL; Watts RL; Watts N; Rye DB; Irbe D; Hughes M
• Clinical utility of beta-hydroxybutyrate determined by reflectance meter in the management of diabetic ketoacidosis.
  Diabetes Care Volume: 18 Page(s): 137 - 138
  01/01/1995 Authors: Umpierrez GE; Watts NB; Phillips LS
• Treatment of osteoporosis with bisphosphonates.
  Rheum Dis Clin North Am Volume: 20 Page(s): 717 - 734
  08/01/1994 Authors: Watts NB
• Endocrinology.
  JAMA Volume: 271 Page(s): 1666 - 1668
  06/01/1994 Authors: Watts NB; Blevins LS
• Bone histomorphometric changes after cyclic therapy with phosphate and etidronate disodium in women with postmenopausal osteoporosis.
  J Clin Endocrinol Metab Volume: 78 Page(s): 968 - 972
  04/01/1994 Authors: Ott SM; Woodson GC; Huffer WE; Miller PD; Watts NB
• Osteoporosis. Methods to prevent fractures in patients at high risk.
  Postgrad Med Volume: 95 Page(s): 73 - 88
  04/01/1994 Authors: Watts NB
• Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.
  Am J Med Volume: 95 Page(s): 557 - 567
  12/01/1993 Authors: Harris ST; Watts NB; Jackson RD; Genant HK; Wasnich RD; Ross P; Miller PD; Licata AA; Chesnut CH
• Value of technetium 99m sestamibi iodine 123 imaging in reoperative parathyroid surgery.
  Surgery Volume: 114 Page(s): 1011 - 1018
  12/01/1993 Authors: Weber CJ; Vansant J; Alazraki N; Christy J; Watts N; Phillips LS; Mansour K; Sewell W; McGarity WC
• Bedside monitoring of blood glucose in hospitals. Speed vs precision and accuracy.
  Arch Pathol Lab Med Volume: 117 Page(s): 1078 - 1079
  11/01/1993 Authors: Watts NB
• Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure.
  J Neurosurg Volume: 78 Page(s): 205 - 215
  02/01/1993 Authors: Tindall GT; Oyesiku NM; Watts NB; Clark RV; Christy JH; Adams DA
• Bisphosphonate therapy for postmenopausal osteoporosis.
  South Med J Volume: 85 Page(s): 2S31 - 2S33
  08/01/1992 Authors: Watts NB
• Albuminuria and diabetic nephropathy: an evolving story.
  Clin Chem Volume: 37 Page(s): 2027 - 2028
  12/01/1991 Authors: Watts NB
• Prevention of osteoporosis: the role of primary physicians.
  J Fam Pract Volume: 32 Page(s): 261 - 263
  03/01/1991 Authors: Watts NB
• Cyclical etidronate treatment of osteoporosis.
  N Engl J Med Volume: 323 Page(s): 1633 - 1635
  12/06/1990
• Changes in endocrine function after adrenal medullary transplantation to the central nervous system.
  J Clin Endocrinol Metab Volume: 71 Page(s): 773 - 776
  09/01/1990 Authors: Watts NB; Clark RV; Watts RL; Graham SD; Bakay RA
• Intermittent cyclical etidronate treatment of postmenopausal osteoporosis.
  N Engl J Med Volume: 323 Page(s): 73 - 79
  07/12/1990 Authors: Watts NB; Harris ST; Genant HK; Wasnich RD; Miller PD; Jackson RD; Licata AA; Ross P; Woodson GC; Yanover MJ
• Individualized goal setting for diabetic control.
  Diabetes Care Volume: 13 Page(s): 811 - 812
  07/01/1990 Authors: Watts NB
• Carbohydrate tolerance improves with fasting in obese subjects with noninsulin-dependent (type II) diabetes.
  Am J Med Sci Volume: 299 Page(s): 250 - 256
  04/01/1990 Authors: Watts NB; DiGirolamo M
• Prediction of glucose response to weight loss in patients with non-insulin-dependent diabetes mellitus.
  Arch Intern Med Volume: 150 Page(s): 803 - 806
  04/01/1990 Authors: Watts NB; Spanheimer RG; DiGirolamo M; Gebhart SS; Musey VC; Siddiq YK; Phillips LS
• Cushing's disease: results of transsphenoidal microsurgery with emphasis on surgical failures.
  J Neurosurg Volume: 72 Page(s): 363 - 369
  03/01/1990 Authors: Tindall GT; Herring CJ; Clark RV; Adams DA; Watts NB
• Preliminary report on adrenal-brain transplantation for parkinsonism in man.
  Stereotact Funct Neurosurg Volume: 54-55 Page(s): 312 - 323
  01/01/1990 Authors: Bakay RA; Watts RL; Freeman A; Iuvone PM; Watts N; Graham SD
• Perioperative glucose control in diabetic patients--strategies for the 1990s.
  West J Med Volume: 151 Page(s): 552 - 553
  11/01/1989 Authors: Watts NB
• Sialadenitis mimicking metastatic thyroid carcinoma.
  Clin Nucl Med Volume: 14 Page(s): 564 - 566
  08/01/1989 Authors: Kolla IS; Alazraki NP; Watts NB
• Reversible impairment of gonadotropin secretion in critical illness. Observations in postmenopausal women.
  Arch Intern Med Volume: 149 Page(s): 1637 - 1641
  07/01/1989 Authors: Gebhart SS; Watts NB; Clark RV; Umpierrez G; Sgoutas D
• Use of a sensitive thyrotropin assay for monitoring treatment with levothyroxine.
  Arch Intern Med Volume: 149 Page(s): 309 - 312
  02/01/1989 Authors: Watts NB
• Osteoporosis.
  Am Fam Physician Volume: 38 Page(s): 193 - 207
  11/01/1988 Authors: Watts NB
• Carcinomatous involvement of the thyroid presenting as subacute thyroiditis.
  Am J Med Sci Volume: 296 Page(s): 126 - 128
  08/01/1988 Authors: Watts NB; Sewell CW
• Medical relevance of laboratory tests. A clinical perspective.
  Arch Pathol Lab Med Volume: 112 Page(s): 379 - 382
  04/01/1988 Authors: Watts NB
• Rapid assessment of corticotropin reserve after pituitary surgery.
  JAMA Volume: 259 Page(s): 708 - 711
  02/05/1988 Authors: Watts NB; Tindall GT
• Suppressive therapy with levothyroxine for solitary thyroid nodules.
  N Engl J Med Volume: 317 Page(s): 1663 - 1665
  12/24/1987
• Postoperative management of diabetes mellitus: steady-state glucose control with bedside algorithm for insulin adjustment.
  Diabetes Care Volume: 10 Page(s): 722 - 728
  01/01/1987 Authors: Watts NB; Gebhart SS; Clark RV; Phillips LS
• Carcinoma metastatic to the thyroid: prevalence and diagnosis by fine-needle aspiration cytology.
  Am J Med Sci Volume: 293 Page(s): 13 - 17
  01/01/1987 Authors: Watts NB
• Solitary thyroid nodules.
  J Med Assoc Ga Volume: 74 Page(s): 710 - 714
  10/01/1985 Authors: Watts NB